https://en.bioecon.ru/oecd/biotech-health/Recent content in Biotech-Health on BioeconHugoen-USSun, 26 Jul 2026 20:07:47 +0700https://en.bioecon.ru/technology/cloud-laboratories/Sat, 25 Jul 2026 22:10:00 +0000https://en.bioecon.ru/technology/cloud-laboratories/Multi-tenant, remotely operated wet labs that execute user-submitted protocols via API and return structured data — the layer that turns biology into programmable infrastructure, decoupling experiment design from bench work and feeding the closed-loop AI-driven autonomous lab.https://en.bioecon.ru/technology/biosafety-lab-biosecurity/Thu, 23 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/biosafety-lab-biosecurity/Physical-containment infrastructure — biological safety cabinets, HEPA filtration, autoclave sterilization and BSL-1 to BSL-4 containment — that protects personnel, product and environment in every biotechnology laboratory, governed by NSF/ANSI 49 and EN 12469.https://en.bioecon.ru/technology/reference-materials-certified-reference-strains/Thu, 23 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/reference-materials-certified-reference-strains/Authenticated microbial type strains and WHO biological reference materials — the calibrated living standards underpinning pharmaceutical QC, diagnostics, taxonomy and patent deposit, held by a global network of biological resource centers from the century-old ATCC to NIBSC.https://en.bioecon.ru/technology/ai-optical-coherence-tomography-screening/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/ai-optical-coherence-tomography-screening/AI-assisted optical coherence tomography and fundus imaging for broad-disease eye screening — diabetic retinopathy, age-related macular degeneration and glaucoma — spanning home-use monitoring devices, multimodal clinic platforms and autonomous AI diagnostic software: Notal Vision and iHealthScreen in the US, Topcon Healthcare (Japan), RetinAI in Switzerland (acquired by EssilorLuxottica), and Airdoc in China.https://en.bioecon.ru/technology/biobanks-human-population-samples/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/biobanks-human-population-samples/Physical infrastructure for collecting, processing, cryopreserving and distributing human biospecimens at population or clinical-trial scale — the biospecimen logistics layer, not the genomic-data repository itself: UK Biobank in the EU, BioLife Solutions and Discovery Life Sciences in the US, the China National GeneBank in China, and the newly inaugurated Phenome-India National Biobank (CSIR-IGIB) in India.https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/Electroceutical devices that treat disease by electrically stimulating nerves rather than with drugs — vagus and splenic nerve neuroimmune modulation, AI-personalized spinal cord stimulation, hypoglossal nerve stimulation and implantable neuromodulation for paralysis and neurological disease: SetPoint Medical, Nevro Corp and Inspire Medical Systems in the US, Galvani Bioelectronics and Onward Medical in Europe, and PINS Medical in China.https://en.bioecon.ru/technology/biomimetic-medical-adhesives/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/biomimetic-medical-adhesives/Bio-inspired surgical adhesives, sealants and hemostatic gels that bond, seal or stop bleeding in wet tissue environments where conventional sutures and staples struggle — drawing on biological adhesion mechanisms such as mussel/oyster adhesive proteins: Tissium in France, Cresilon and Brij Medical in the US, and Adhesys Medical in Germany.https://en.bioecon.ru/technology/bionic-prostheses-neuroprosthetics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/bionic-prostheses-neuroprosthetics/Prosthetic devices that replace a lost limb’s function through AI-driven control, touch sensing and direct skeletal attachment — dexterous touch-sensing hands, AI neural prosthetic control, myoelectric pattern recognition and osseointegrated prostheses: Psyonic, Atom Limbs and Coapt in the US, Ottobock and Integrum in Europe, and BrainCo (BrainRobotics) in China.https://en.bioecon.ru/technology/companion-diagnostics-platforms/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/companion-diagnostics-platforms/Tissue-based immunohistochemistry (IHC) and FISH platforms that determine whether a specific patient is eligible for a specific targeted therapy, sold and regulated as a companion diagnostic (CDx) tied directly to a drug label — distinct from blood-based liquid-biopsy CDx: Ventana/Roche Tissue Diagnostics, Agilent Dako and Myriad Genetics in the US, 3D Medicines in China, and MedGenome in India.https://en.bioecon.ru/technology/digital-therapeutics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/digital-therapeutics/Software-as-medical-device treatments that deliver a regulator-cleared clinical intervention rather than general wellness support — prescription digital therapeutics for ADHD, insomnia, anxiety and depression, musculoskeletal digital rehabilitation and pediatric autism intervention: Akili Interactive, Big Health and Click Therapeutics in the US, Kaia Health in Germany, and ALSOLIFE in China.https://en.bioecon.ru/technology/exhaled-breath-glucose-monitoring/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/exhaled-breath-glucose-monitoring/Non-invasive breath-analyte devices aiming to monitor diabetes-relevant metabolic state without a fingerstick or implanted sensor — most commercially advanced platforms detect breath acetone/ketones as a metabolic proxy, while newer entrants target a more direct blood-glucose alert claim: PranaQ, Invoy Technologies, LEVL and PREEVNT, all US-based.https://en.bioecon.ru/technology/genomic-pathogen-surveillance/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/genomic-pathogen-surveillance/Sequencing-based services that track pathogen genomic evolution and spread for public health response — traveler/airport biosurveillance, portable field sequencing and national metagenomic surveillance programs — the genomic-analysis service layer, not the sample-collection infrastructure: Ginkgo Bioworks (Concentric) in the US, Oxford Nanopore Technologies and the Wellcome Sanger Institute/UKHSA in the UK, BGI Genomics in China, and the Rajiv Gandhi Centre for Biotechnology in India.https://en.bioecon.ru/technology/home-blood-analysis-kits/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/home-blood-analysis-kits/Self-administered blood collection for consumer health testing, either mailed to a certified laboratory or drawn at a retail microsample station, returning results outside a clinic visit — distinct from clinic point-of-care testing: LetsGetChecked and Everlywell (mail-in kits) and Babson Diagnostics (retail microsample testing) in the US, and Thriva in the UK.https://en.bioecon.ru/technology/implantable-biosensors-chronic-disease/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/implantable-biosensors-chronic-disease/Surgically or subcutaneously implanted sensors that continuously monitor a chronic-disease parameter for months to years without an external wearable — implantable continuous glucose monitors and insertable cardiac monitors — distinct from external wearables and ingested/swallowed sensors: Senseonics’ Eversense 365 in the US, Medtronic’s LINQ II and Boston Scientific’s LUX-Dx cardiac monitors in the US, Biotronik’s BIOMONITOR in Germany, and MicroPort in China.https://en.bioecon.ru/technology/ingestible-biosensors-smart-pills/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/ingestible-biosensors-smart-pills/Swallowed capsule devices that image the GI tract or confirm medication ingestion as they transit the body, requiring no sedation or implantation — distinct from surgically implanted sensors: Medtronic’s PillCam and CapsoVision’s CapsoCam capsule endoscopy in the US, etectRx’s ID-Cap ingestible event marker in the US, and Ankon Technologies’ magnetically controlled capsule endoscopy in China.https://en.bioecon.ru/technology/intraoperative-molecular-diagnostics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/intraoperative-molecular-diagnostics/Real-time, in-the-operating-room molecular and optical tissue identification — fluorescence imaging agents, OCT, stimulated Raman histology and mass-spectrometry tissue analysis — that lets surgeons assess tumor margins during the procedure instead of waiting on frozen-section pathology: On Target Laboratories and Dilon Technologies (fluorescence/RF-spectroscopy margin agents), Perimeter Medical Imaging AI (AI-enabled OCT), Invenio Imaging (stimulated Raman histology) in the US, and photonamic and Imperial College London (iKnife/REIMS) in Europe.https://en.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/Blood-based detection and quantification of circulating tumor DNA (ctDNA) for cancer companion diagnostics and molecular residual disease (MRD) monitoring, replacing or supplementing tissue biopsy — led by Guardant Health, Natera and Foundation Medicine in the US, Sysmex Inostics in the EU, MedGenome in India, and Burning Rock Biotech in China.https://en.bioecon.ru/technology/medical-devices-biointerface/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/medical-devices-biointerface/Surface-engineering and coating technologies that govern how a catheter, guidewire, stent or implant actually meets living tissue — hydrophilic lubricious coatings, bioactive anticoagulant polymer layers, and drug-eluting coating systems — spanning Formacoat, Biocoat and Integer Holdings in the US, Freudenberg Medical and DSM Biomedical in Europe, and Sino Medical Sciences Technology in China.https://en.bioecon.ru/technology/microbiome-diagnostic-panels/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/microbiome-diagnostic-panels/Stool- or swab-based sequencing panels that profile the gut or GI microbiome for consumer wellness insight or clinical pathogen/dysbiosis detection, distinct from general human genomics services: Viome (US, consumer wellness) and Codex Genetics (US, clinical metagenomics), Sequentia Biotech’s IVDR-CE-marked MICK Clinical in Spain, Realbio Genomics in China, and Yaazh Xenomics in India.https://en.bioecon.ru/technology/multi-cancer-early-detection/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/multi-cancer-early-detection/A single blood draw screening asymptomatic, average-risk individuals for signals of dozens of cancer types simultaneously, aiming to catch cancer before symptoms appear — distinct from treatment-matched companion diagnostics: GRAIL’s Galleri (US), Exact Sciences’ Cancerguard (US) and Freenome (US), Novigenix in Switzerland, and Singlera Genomics in China.https://en.bioecon.ru/technology/multi-omics-diagnostic-panels-precision-oncology/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/multi-omics-diagnostic-panels-precision-oncology/Integrative genomic, transcriptomic and proteomic oncology profiling platforms that combine multiple molecular data layers into a single treatment-matching report, broader than a single drug-label companion diagnostic: Tempus AI and Caris Life Sciences in the US, Sophia Genetics in Switzerland, Geneseeq Technology in China, and 1cell.ai in India.https://en.bioecon.ru/technology/partial-epigenetic-reprogramming/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/partial-epigenetic-reprogramming/Transient expression of Yamanaka reprogramming factors to reverse epigenetic markers of cellular aging without erasing cell identity — OSK gene therapy, AI-discovered reprogramming payloads and safer single-gene rejuvenation targets: Altos Labs, Retro Biosciences, NewLimit and Life Biosciences in the US, Shift Bioscience in the UK, and JingTong Life in China.https://en.bioecon.ru/technology/patient-digital-twins-in-silico-trials/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/patient-digital-twins-in-silico-trials/Computational patient models and virtual trial simulations used to reduce, accelerate or de-risk clinical development — AI-generated synthetic control arms, physiologically-based pharmacokinetic modeling, preclinical-to-clinical translation AI and causal-AI virtual patient simulation: Unlearn.AI, Certara and VeriSIM Life in the US, and Novadiscovery (Nova In Silico) in France.https://en.bioecon.ru/technology/point-of-care-molecular-diagnostics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/point-of-care-molecular-diagnostics/Lab-free, sample-to-answer molecular testing platforms delivering PCR-grade results at the bedside, clinic or field site in minutes rather than the hours a central lab requires: Cepheid’s GeneXpert (Danaher) and bioMérieux’s BIOFIRE cartridge-based systems, Abbott’s ID NOW isothermal platform, Sansure Biotech’s domestic POCT scale-up in China, and Molbio Diagnostics’ Truenat chip-based platform serving resource-limited settings from India.https://en.bioecon.ru/technology/rapid-antibiotic-resistance-tests/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/rapid-antibiotic-resistance-tests/Platforms that determine which antibiotics a specific infecting pathogen is susceptible or resistant to in hours instead of the 2-3 days conventional culture-based susceptibility testing requires, guiding targeted rather than empiric antibiotic therapy: Accelerate Diagnostics and T2 Biosystems and Selux Diagnostics in the US, Q-linea in Sweden, and Autobio Diagnostics in China.https://en.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/Eye-scan technologies that detect Alzheimer’s and other neurodegenerative-disease biomarkers directly in the retina — a window onto brain pathology accessible without imaging the brain itself — spanning hyperspectral imaging, OCT-based structural biomarkers and retinal amyloid detection: RetiSpec and NeuroVision Imaging in North America, Optina Diagnostics in Canada, and Heidelberg Engineering in Germany.https://en.bioecon.ru/technology/synthetic-biomarkers/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/synthetic-biomarkers/Engineered, exogenous reporter molecules — activity-based nanosensors, synthetic gene circuits and volatile-organic-compound probes — administered to a patient to generate an amplified, easily measured disease signal that no endogenous biomarker naturally produces: Glympse Bio, Earli and ZymoSense in the US, and Owlstone Medical’s EVOC breath-probe platform in the UK.https://en.bioecon.ru/technology/tear-fluid-biopsy/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/tear-fluid-biopsy/Point-of-care diagnostic testing of a microliter tear sample for dry eye, ocular allergy and inflammatory biomarkers, avoiding blood draw or invasive sampling: Trukera Medical’s tear osmolarity system and Lacrisciences’ tear IgE allergy test and QuidelOrtho’s InflammaDry inflammatory marker test in the US, and DiagnosTear’s TearX platform in France.https://en.bioecon.ru/technology/forest-biopharma-phytochemicals/Thu, 09 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/forest-biopharma-phytochemicals/Forest- and plant-derived pharmaceutical compounds and phytochemicals — paclitaxel from Taxus, curcumin, aged-black-garlic and standardized botanical extracts — produced by Phyton Biotech, Indena, Sabinsa, Natural Remedies and Pharmactive.https://en.bioecon.ru/technology/epigenetic-clocks-biological-age-diagnostics/Mon, 06 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/epigenetic-clocks-biological-age-diagnostics/Reading DNA-methylation patterns across hundreds of thousands of CpG sites to compute a person’s biological age and pace of aging, rather than the calendar age on a birth certificate, turning a $229-799 saliva or blood test into the primary read-out for the longevity industry.https://en.bioecon.ru/technology/urban-microbiome-management/Mon, 06 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/urban-microbiome-management/Mapping and deliberately shaping the microbial communities that colonize subways, offices and hospitals — global metagenomic swabbing consortia that sequence a city’s aerobiome, probiotic surface cleaners that seed beneficial microbes instead of sterilizing every surface, and building-science research on how mass-timber and ventilation design shift indoor microbial ecology — treating a city’s invisible biology as infrastructure to be measured and managed rather than eliminated.https://en.bioecon.ru/technology/consumer-neurotech-wellness-bci-eeg/Sun, 05 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/consumer-neurotech-wellness-bci-eeg/Dry-electrode EEG wearables — headbands, earbuds and sleep masks — that read brainwave activity without gel or clinical setup, using on-device AI artifact removal and neurofeedback training to support meditation, focus and sleep, regulated as general wellness devices rather than medical BCI.https://en.bioecon.ru/technology/dna-nanotechnology-dna-origami/Fri, 03 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/dna-nanotechnology-dna-origami/Folding single-stranded DNA into precision-programmed 3D nanostructures — drug-delivery nanorobots, vaccine scaffolds and metrology nanorulers.https://en.bioecon.ru/technology/veterinary-genomics-companion-animal-diagnostics/Fri, 03 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/veterinary-genomics-companion-animal-diagnostics/Direct-to-consumer DNA testing of dogs and cats — a stack from cheek-swab collection to a LIMS-verified veterinary genetic passport screening hundreds of inherited disease risks.https://en.bioecon.ru/technology/ai-pathology-interpretation/Tue, 30 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/ai-pathology-interpretation/AI interpretation of digitized whole-slide histology images using self-supervised vision transformers and attention multiple-instance learning to detect tumour foci, grade cancer (Gleason) and predict molecular biomarkers (MSI, PD-L1) from morphology, cutting diagnosis time from days to minutes.https://en.bioecon.ru/technology/dtc-genetic-testing/Tue, 30 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/dtc-genetic-testing/Direct-to-consumer genetic testing from saliva via SNP genotyping arrays and 30x whole-genome sequencing, with bioinformatic polygenic risk scoring and telemedicine gating of pathogenic findings (BRCA1/2), under FDA 510(k), EU IVDR and China’s genetic-data sovereignty rules.https://en.bioecon.ru/technology/one-health-zoonosis-amr-monitoring/Tue, 30 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/one-health-zoonosis-amr-monitoring/Outsourced One Health surveillance that fuses veterinary, human and environmental sampling with shotgun metagenomic sequencing, CARD resistome profiling and AI spillover-risk scoring to detect zoonotic pathogens and antimicrobial resistance, delivered as an ISO 17025 reference-lab service under EU 2003/99/EC, US NARMS and China’s containment plan.https://en.bioecon.ru/technology/biomedical-engineering-implants/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/biomedical-engineering-implants/The engineering of medical devices that interface with the body — orthopedic, cardiovascular and neuro implants — sold as capital robotic systems, per-procedure implants and regulated biomaterials under FDA, EU MDR and NMPA oversight.https://en.bioecon.ru/technology/femtech-biotech-womens-health/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/femtech-biotech-womens-health/Specialized biologic, diagnostic and live-biotherapeutic products for conditions that affect exclusively or disproportionately women — non-invasive endometriosis testing, ovarian-longevity therapeutics, vaginal-microbiome LBPs and cfDNA prenatal screening, under FDA, EU IVDR/EMA and NMPA oversight.https://en.bioecon.ru/technology/neurointerfaces-bci/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/neurointerfaces-bci/Brain–computer interfaces that read motor and speech cortex activity and decode intent into text, synthesized voice or robotic movement — spanning invasive intracortical arrays, endovascular stent-electrodes, semi-invasive ECoG and non-invasive EEG, under FDA IDE trials, EU MDR and NMPA oversight.https://en.bioecon.ru/technology/personalized-nutrition/Fri, 26 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/personalized-nutrition/Dietary recommendations tailored to an individual’s gut microbiome, DNA and real-time glucose response, delivered as test-kit subscriptions, AI food scores and custom-formulated supplements.https://en.bioecon.ru/technology/breathomics/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/breathomics/Non-invasive breath analysis using VOC patterns for early diagnosis and continuous disease monitoring.https://en.bioecon.ru/technology/generative-protein-design/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/generative-protein-design/Creating completely novel, non-natural protein structures and sequences from scratch using diffusion networks and large language models for therapeutics and biosensors.https://en.bioecon.ru/technology/lab-automation-wet-lab-robotics/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/lab-automation-wet-lab-robotics/High-throughput robotic systems and liquid handling workstations driving autonomous, reproducible bio-research and screening.https://en.bioecon.ru/technology/organoids-organ-on-chip/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/organoids-organ-on-chip/Microphysiological systems mimicking human organs in vitro to replace animal testing and accelerate personalized medicine.https://en.bioecon.ru/technology/personalized-diagnostics/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/personalized-diagnostics/Molecular diagnostics leveraging NGS, liquid biopsy, and AI for precision medicine and targeted therapies.https://en.bioecon.ru/technology/veterinary-biotech-mrna-drugs/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/veterinary-biotech-mrna-drugs/Advanced veterinary biotechnology focusing on mRNA vaccines, recombinant proteins, and novel biologics to combat zoonotic and livestock diseases with rapid-response platforms.https://en.bioecon.ru/technology/wearable-biodiagnostics/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/wearable-biodiagnostics/Wearable biodiagnostics and continuous monitoring systems enabling real-time precision health management.https://en.bioecon.ru/technology/modular-mobile-cleanrooms/Wed, 24 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/modular-mobile-cleanrooms/Prefabricated, autonomous cleanroom infrastructures delivering rapid deployment, scalable capacity, and guaranteed cGMP compliance for the rapidly evolving biomanufacturing and cell therapy sectors.https://en.bioecon.ru/technology/crispr-diagnostics/Sun, 14 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/crispr-diagnostics/Cas-enzyme nucleic-acid detection — point-of-care molecular diagnostics from sample to lateral-flow readout.